Our research results show that GA ameliorates E.granulosus infection-mediated hepatic fibrosis by specifically inhibiting SUMOylation of Smad4 in macrophages through targeted modulation of the SUMOylation pathway, thereby hindering pathogenic macrophage-hepatic stellate cell crosstalk. Here, SMAD4 is linked to Hepatic fibrosis.